2022
Nanoparticles: The Promising Future of Advanced Diagnosis and Treatment of Neurological Disorders
Nuthalapati P, Asaithambi S, Kumar M, Reddy D. Nanoparticles: The Promising Future of Advanced Diagnosis and Treatment of Neurological Disorders. 2022, 221-234. DOI: 10.1201/9781003157823-18.Peer-Reviewed Original ResearchBlood-brain barrierMultiple sclerosisLimitations of current therapiesNeurological disordersParkinson's diseaseHuntington's diseaseCurrent therapiesClinical studiesTransport drugsNanoparticle strategiesIntroduction of nanotechnologyNoninvasive techniqueNanoparticle technologyDiseaseDrugDamaged nervous tissuePersistent luminescence imagingAdvanced diagnosisEtiologyGold nanoparticlesBrainDisordersNervous tissueDisease treatmentSclerosis
2021
Molecular docking study of Momordica charantia Linn phytoconstituent with caspase 3 and implications for renoprotective actions in diabetes mellitus
Ghanta M, Nayaka S, Nuthalapati P, Afzal Khan A, Elango P, Lakkakula B. Molecular docking study of Momordica charantia Linn phytoconstituent with caspase 3 and implications for renoprotective actions in diabetes mellitus. Journal Of Nephropharmacology 2021 DOI: 10.34172/npj.2022.10394.Peer-Reviewed Original ResearchD-galacturonic acidCaspase 3Amino acid interactionsCaspase 3 enzymeAnti-apoptotic agentApoptosis executionerPDB databaseProtein structurePlant extractsCaspaseMolecular docking studiesAcid interactionsNeurodegenerative disease treatmentGlu124AutoDock versionBitter melon extractLys137Pectin compositionBitter melonMedicinal propertiesMelon extractMomordica charantiaPlantsPubChem databaseDisease treatment